GoConnect Limited (NSX:GO8) advise that COVIRIX Medical and Numolux Group have entered into a strategic partnership for anti-viral drug development platform.
GoConnect Limited (NSX:GO8) is pleased to advise that COVIRIX Medical Pty Ltd, of which Go Green Holdings Ltd has a 24% interest, has been granted a 20 years patent by IP Australia for the company s repurposed antiviral treatment and prevention of pulmonary infections.